Literature DB >> 17522868

[Secondary open angle glaucoma with idiopathic episcleral venous pressure (Radius-Maumenee syndrome). Sinus-otomy as operative procedure of choice].

R Lämmer.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17522868     DOI: 10.1007/s00347-007-1519-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  4 in total

1.  Externalization of Schlemm's canal (sinusotomy) in glaucoma.

Authors:  M M Krasnov
Journal:  Br J Ophthalmol       Date:  1968-02       Impact factor: 4.638

2.  Angioarchitecture and innervation of the primate anterior episclera.

Authors:  J Michael Selbach; Johannes W Rohen; Klaus-Peter Steuhl; Elke Lütjen-Drecoll
Journal:  Curr Eye Res       Date:  2005-05       Impact factor: 2.424

3.  [Unilateral secondary open-angle glaucoma with idiopathically dilated episcleral vessels].

Authors:  K W Ruprecht; G O Naumann
Journal:  Klin Monbl Augenheilkd       Date:  1984-01       Impact factor: 0.700

4.  Dilated episcleral vessels and open-angle glaucoma.

Authors:  R L Radius; A E Maumenee
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

  4 in total
  3 in total

Review 1.  [Glaucoma due to elevated episcleral venous pressure].

Authors:  R Greslechner; I Oberacher-Velten
Journal:  Ophthalmologe       Date:  2019-05       Impact factor: 1.059

2.  [Management of Radius-Maumenee syndrome : Treatment with deep sclerectomy, viscocanalostomy and collagen matrix implantation].

Authors:  S Kazerounian; A Rickmann; K Helaiwa; M Waizel
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

Review 3.  [Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Authors:  Roman Greslechner; Horst Helbig; Detlev Spiegel
Journal:  Ophthalmologe       Date:  2022-04-26       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.